Company intelligence / Profile preview

Cencora

Conshohocken, Pennsylvania, United Statescencora.com ↗

Ownership: Public · COR
Employees: ~46000
Development stage: Commercial

Overview

Cencora provides pharmaceutical sourcing/distribution services globally for human and animal health. It enables access to therapies by supporting manufacturers with logistics from clinical trials to product launch and offers tailored pharmacy support programs. The company operates in more than 50 countries with over $290 billion in annual revenue.[4][6] No clinical trial results are reported since it does not develop drugs.

Modalities: small moleculesbiologics (such as mAbs)genericsspecialty drugsover-the-counter products[5][6]
Industry: Drug Discovery Services

Partnerships

Partners with pharmaceutical innovators/manufacturers globally to facilitate therapy success and optimize access to care[1][3][6]

Financials

Market cap: $62.9B
Total revenue: $84.8B
Enterprise value: $71.8B

Beyond the preview

Go deeper on Cencora.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cencora.

Explore the full profile